अ

Welcome to Arth Vani

Choose your preferred language

Sponsored · Open a free Demat account & get ₹500 in stocks.Claim
अ
ArthVani
Nifty 5024,187.70.21%H 24,262.2 · L 24,135.65|Sensex77,470.110.31%H 77,753.18 · L 77,337.33|Bank Nifty57,835.350.19%H 58,228.65 · L 57,803.85|USD / INR₹96.230.21%H ₹96.45 · L ₹96.11|Gold Intl (10g)₹1,25,372.980.9%H ₹1,26,496.11 · L ₹1,23,863.09|Silver Intl (1kg)₹1,81,309.852.68%H ₹1,84,249.18 · L ₹1,74,441.12|Crude WTI₹8,158.82.79%H ₹8,163.62 · L ₹7,832.57|Bitcoin₹63,87,4312.62%H ₹64,71,109.6 · L ₹63,03,752.4|Ethereum₹1,85,7093%H ₹1,88,491.75 · L ₹1,82,926.25|Nifty 5024,187.70.21%H 24,262.2 · L 24,135.65|Sensex77,470.110.31%H 77,753.18 · L 77,337.33|Bank Nifty57,835.350.19%H 58,228.65 · L 57,803.85|USD / INR₹96.230.21%H ₹96.45 · L ₹96.11|Gold Intl (10g)₹1,25,372.980.9%H ₹1,26,496.11 · L ₹1,23,863.09|Silver Intl (1kg)₹1,81,309.852.68%H ₹1,84,249.18 · L ₹1,74,441.12|Crude WTI₹8,158.82.79%H ₹8,163.62 · L ₹7,832.57|Bitcoin₹63,87,4312.62%H ₹64,71,109.6 · L ₹63,03,752.4|Ethereum₹1,85,7093%H ₹1,88,491.75 · L ₹1,82,926.25|
BreakingRupee Makes Strong Comeback: First Quarterly Gain in Five Quarters1/6
Topicin real-estate

Generic Drugs

Latest news, explainers and analysis on Generic Drugs. Tracking 1 stories on Arth Vani.

1 stories tracked

Latest on Generic Drugs

Alembic & NATCO Get USFDA Nod for Cancer Drug; Big Market Opportunity
real-estate

Alembic & NATCO Get USFDA Nod for Cancer Drug; Big Market Opportunity

Indian pharmaceutical firms Alembic Pharmaceuticals and NATCO Pharma have received tentative USFDA approval for a generic version of the cancer drug Olaparib. This approval opens up a significant market opportunity in the US, estimated at ₹11,660 crore, though the commercial launch is contingent on ongoing legal proceedings.

2d ago·2 min readListen
real-estate products
Compare & act on the right product for this topic
Smart picks
HDFC NIFTY Next 50 Index Fund
HDFC Mutual Fund · Index
18.2%
3Y CAGR
Nippon India Small Cap Fund Growth Plan
Nippon India Mutual Fund · Small Cap
17.6%
3Y CAGR
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
14.6%
3Y CAGR
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
14.2%
3Y CAGR
HDFC Balanced Advantage Fund
HDFC Mutual Fund · Hybrid
13.9%
3Y CAGR
ICICI Prudential Balanced Advantage Fund
ICICI Prudential Mutual Fund · Hybrid
12.1%
3Y CAGR
Compare & decide
All comparisons
Read comparison

Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.

Explore all entities in the Knowledge Graph

Daily 3-minute money update on WhatsApp

Join 50,000+ investors — free.